Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer
Virginia Sun(City of Hope), Marcia Grant(City of Hope), Amy Hakim(City Of Hope National Medical Center), Shirley Otis‐Green(City of Hope), Robert J. Morgan(Mayo Clinic), Eunice Yang(Alaska Heart and Vascular Institute), Betty Ferrell(University of Colorado Anschutz Medical Campus), Maria Elenita Callado(City of Hope), Mark T. Wakabayashi(City Of Hope National Medical Center)
Cited by 9
Related Papers
Medical large language models are vulnerable to data-poisoning attacks
|Nature Medicine|2025|171
Left Atrial LGE and Arrhythmia Recurrence Following Pulmonary Vein Isolation for Paroxysmal and Persistent AF
|JACC. Cardiovascular imaging|2016|118
Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking
|Radiology|2018|99
Urotensin II Promotes Hypertrophy of Cardiac Myocytes via Mitogen-Activated Protein Kinases
|Molecular Endocrinology|2004|89
Cervical cancer vaccines: Emerging concepts and developments
|Journal of Cellular Physiology|2001|88